The e-commerce giant is in the early stages of consideration and the IPO's size is yet to be determined, the report added
Rivals General Motors Co and Samsung SDI are also set to announce plans to build a joint venture EV battery manufacturing plant in the U.S., sources said
Short interest in First Republic indeed increased as turmoil in the banking sector intensified, although measures vary
The scrutiny of bank stock, which will kick off the earnings season, will be more this time in the wake of the two biggest bank failures since the 2008 financial crisis
Silicon Valley Bank crisis: How has the bank's failure affected other banks and their stocks worldwide? Read more to find out
US inflation, Nomura said, is still elevated and the Fed will look to bring it down going ahead.
About 60% are recurring depositors, many are particpants in some of the leading stocks and ETFs in America
A month after opening its first American outlet, Tanishq, India's leading jewelry retail brand from the house of Tata, feels that the United States offers huge opportunities for not only itself but also for other Indian retail brands as well. This is mainly attributed to the large presence of Indian Diaspora in the country, who are among the highest per-capita income, but also because of the interest in India, its culture and products among the Americans. "The opportunity is huge. Just from an Indian diaspora perspective, a South Asian diaspora perspective, and then even beyond that, the opportunity is huge. If you just focus on, let's say the Indian diaspora part, the people here, and that is an important part of our decision to enter here, said Amrit Pal Singh, business head- North America, Titan Company that runs the chain of jewelry stores in both India and overseas under the brand of Tanishq. Before entering the US market, Tanishq spent two years in studying the North American
Markets feel that US central bank's aggressive rate hike cycle may be nearing an end
Fall in US dollar index seen providing revaluation boost to RBI reserves
Both shed 0.6% but end in green for second straight week; Broader markets play catch-up
Offer document open to scrutiny only by regulator, exchanges; the Walt Disney Company-led firm eyeing a Rs 3,000-crore IPO
Primary market momentum seen sustaining in an otherwise 'lacklustre' month
Wall Street is heading lower ahead of Monday's opening bell amid widespread protests in China calling for Xi Jinping to step down and an end to one-party rule. Futures for the Dow Jones industrials fell 0.5 per cent and the S and P slipped 0.7 per cent. Crude prices neared a low point for the year partially due to unrest in China, and have fallen for three consecutive weeks. Crude prices are now negative for 2022 and, after soaring above USD 120 in June, a barrel of benchmark US crude can now be had for less than USD 74 per barrel. The upheaval in China is the greatest show of public dissent against the ruling Communist Party in decades. Protestors are railing against policies aimed at eradicating the coronavirus by isolating every case, a policy that may have contributed to the death toll in an apartment fire in Urumqi in the northwestern Xinjiang region. For investors, when it comes to China, trying to predict with any degree the reopening certainty that has no certainty, basis,
Among the lot, US equities still have a lot of room to catch up as the US Federal Reserve (US Fed) slows its pace of rate hikes, analysts say
Bankman-Fried's trading firm Alameda Research is also part of the bankruptcy protection
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator. According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets. The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc. As per the USFDA, the company is recalling the affected lot due to "Current good manufacturing practices CGMP deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit." Nitrosamines are a group of compounds which can damage DNA in the long term. The company, a unit of Hyderabad-based Aurobindo Pharma, initiated the Class II voluntary recall on October 5 this year. In a separate statement, USFDA said AuroMedics Pharma LLC, a unit of Aurobindo Phar
On Wednesday, US Fedral Bank increased repo rate by 75 basis points, taking the key repo rate to 4 per cent
US and European shares rose on Monday as signs of a cooling U.S. economy raised hopes that the Federal Reserve will slow its pace of rate hikes
Asian stocks wallowed at two-year lows, after a strengthening dollar, instability in the UK bond market, and upcoming US inflation data spelled a wild session on Wall Street